anaxirone has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hilgard, P; Peukert, M; Pohl, J | 1 |
| Bieser, W; Fiebig, HH; Henss, H; Lohr, GW; Schmid, JR | 1 |
2 other study(ies) available for anaxirone and Experimental Neoplasms
| Article | Year |
|---|---|
alpha-/beta-Triglycidyl-urazol (TGU, NSC 332488, I.N.N.: ANAXIRONE): a new chemotherapeutic agent.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Drug Evaluation; Drug Evaluation, Preclinical; Humans; Kinetics; Metabolic Clearance Rate; Mice; Neoplasms; Neoplasms, Experimental; Rats; Triazines; Triazoles | 1984 |
Colony assay with human tumor xenografts, murine tumors and human bone marrow. Potential for anticancer drug development.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Cell Division; Cell Survival; Cells, Cultured; Colony-Forming Units Assay; Dose-Response Relationship, Drug; In Vitro Techniques; Mice; Mice, Nude; Neoplasms, Experimental; Ribavirin; Transplantation, Heterologous; Triazoles | 1987 |